ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,544,138 | -19.5% | 2,567,858 | +4.2% | 0.01% | -16.7% |
| Q2 2023 | $113,731,209 | +3.3% | 2,465,450 | -10.2% | 0.01% | 0.0% |
| Q1 2023 | $110,102,546 | -59.6% | 2,745,707 | -53.3% | 0.01% | -25.0% |
| Q4 2022 | $272,676,790 | +157.3% | 5,885,534 | +129.9% | 0.01% | +14.3% |
| Q3 2022 | $105,991,000 | -27.7% | 2,559,544 | +4.2% | 0.01% | -22.2% |
| Q2 2022 | $146,603,000 | +3.6% | 2,457,308 | +26.1% | 0.01% | +28.6% |
| Q1 2022 | $141,513,000 | +0.2% | 1,948,684 | +16.1% | 0.01% | 0.0% |
| Q4 2021 | $141,174,000 | +6.2% | 1,678,841 | +13.9% | 0.01% | 0.0% |
| Q3 2021 | $132,928,000 | +1.7% | 1,473,865 | +7.5% | 0.01% | 0.0% |
| Q2 2021 | $130,713,000 | -28.7% | 1,370,875 | -14.9% | 0.01% | -36.4% |
| Q1 2021 | $183,410,000 | -21.0% | 1,610,839 | -3.9% | 0.01% | -21.4% |
| Q4 2020 | $232,050,000 | +55.4% | 1,676,299 | -7.7% | 0.01% | +40.0% |
| Q3 2020 | $149,339,000 | -3.5% | 1,816,992 | -8.2% | 0.01% | -9.1% |
| Q2 2020 | $154,738,000 | +56.2% | 1,978,244 | -11.3% | 0.01% | +22.2% |
| Q1 2020 | $99,050,000 | +5.5% | 2,229,351 | +1.4% | 0.01% | +50.0% |
| Q4 2019 | $93,908,000 | +4.0% | 2,198,747 | +4.2% | 0.01% | -14.3% |
| Q3 2019 | $90,304,000 | -32.9% | 2,110,888 | -0.4% | 0.01% | -30.0% |
| Q2 2019 | $134,603,000 | +1.0% | 2,119,732 | +10.3% | 0.01% | 0.0% |
| Q1 2019 | $133,290,000 | +49.4% | 1,921,711 | -6.3% | 0.01% | +25.0% |
| Q4 2018 | $89,205,000 | -31.8% | 2,051,639 | +19.8% | 0.01% | -20.0% |
| Q3 2018 | $130,735,000 | +3.2% | 1,712,524 | +3.9% | 0.01% | -9.1% |
| Q2 2018 | $126,736,000 | +23.2% | 1,648,751 | -18.3% | 0.01% | +22.2% |
| Q1 2018 | $102,864,000 | +38.9% | 2,017,295 | +26.4% | 0.01% | +50.0% |
| Q4 2017 | $74,050,000 | -8.2% | 1,596,519 | +5.4% | 0.01% | -14.3% |
| Q3 2017 | $80,689,000 | -15.4% | 1,515,071 | -1.4% | 0.01% | -12.5% |
| Q2 2017 | $95,417,000 | +11.2% | 1,536,285 | +21.4% | 0.01% | 0.0% |
| Q1 2017 | $85,784,000 | -12.7% | 1,265,556 | -9.4% | 0.01% | -11.1% |
| Q4 2016 | $98,227,000 | -6.3% | 1,397,189 | -5.4% | 0.01% | -18.2% |
| Q3 2016 | $104,807,000 | +68.9% | 1,477,436 | +16.5% | 0.01% | +57.1% |
| Q2 2016 | $62,048,000 | -23.7% | 1,268,686 | -1.2% | 0.01% | -22.2% |
| Q1 2016 | $81,315,000 | -26.3% | 1,284,324 | +30.6% | 0.01% | -25.0% |
| Q4 2015 | $110,321,000 | +33.7% | 983,423 | +14.8% | 0.01% | +20.0% |
| Q3 2015 | $82,525,000 | -3.7% | 856,881 | +2.4% | 0.01% | +11.1% |
| Q2 2015 | $85,705,000 | +165.5% | 837,050 | +61.0% | 0.01% | +200.0% |
| Q1 2015 | $32,285,000 | +39.9% | 519,987 | -1.1% | 0.00% | +50.0% |
| Q4 2014 | $23,072,000 | +7.6% | 525,781 | +38.8% | 0.00% | 0.0% |
| Q3 2014 | $21,445,000 | +420.5% | 378,865 | +312.4% | 0.00% | – |
| Q2 2014 | $4,120,000 | +31.6% | 91,870 | +43.6% | 0.00% | – |
| Q1 2014 | $3,131,000 | – | 63,981 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |